14170 Semaglutide for Sale
Compare supplier listings for Semaglutide (CAS 2924330-56-1) — check price, grade and packaging, then open a product page or send an inquiry. View Suppliers
Semaglutide 99% High Purity Cosmetic Raw Material 5 mg per Vial
-
Price:
$20-25/G FOB
-
CAS No.:
910463-68-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
5mg per Vial
peptides
.,证书
Semaglutide (SM02) 99% High Purity Cosmetic Raw Material 2 mg per Vial
-
Price:
$20-25/G FOB
-
CAS No.:
1208243-50-8
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
2mg per Vial
peptides
.,证书
Semaglutide 99%+ High Purity Cosmetic Raw Material Multiple Sizes: 2 mg / 5 mg / 10 mg / 15 mg / 20 mg / 30 mg per Vial
-
Price:
$21-26/G FOB
-
CAS No.:
910463-68-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
2 mg / 5 mg / 10 mg / 15 mg / 20 mg / 30 mg per Vial
peptides
.,证书
Semaglutide 99%+ High Purity Cosmetic Raw Material Multiple Specifications: 2 mg / 5 mg / 10 mg / 15 mg / 20 mg / 30 mg per vial
-
Price:
$21-26/G FOB
-
CAS No.:
910463-68-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
2 mg/vial 5mg/vial 10mg/vial 15mg/vial 30mg/vial
peptides
.,证书
Cost accessible price Retatrutide Multi functional effects peptides First rate quality
-
Price:
$20-25/G FOB
-
CAS No.:
2381089-83-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
5 mg/vial 10 mg/vial 15 mg/vial 20 mg/vial
peptides
.,证书
Products You May Be Interested in
Factory direct sales Lyophilized peptide Retatrutide-Freeze-dried peptide powder for weight control
-
Price:
$20-25/G FOB
-
CAS No.:
2381089-83-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
5 mg/vial 10 mg/vial 15 mg/vial 20 mg/vial
peptides
.,证书
Cost accessible price Retatrutide Multi functional effects peptides First rate quality 2381089-83-2
-
Price:
$20-25/G FOB
-
CAS No.:
2381089-83-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
5 mg/vial 10 mg/vial 15 mg/vial 20 mg/vial
peptides
.,证书
99% Purity Peptides Retatrutide Epithalon Tirzepatide Cagrilintide Kpv Thymosin Alpha-1 307297-39-8
-
Price:
$20-25/G FOB
-
CAS No.:
307297-39-8
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
10 mg/vial 50mg*10vials
peptides
.,证书
Best Oxytocin Acetate vials price Pure Oxytocin raw powder 50-56-6
-
Price:
$20-25/G FOB
-
CAS No.:
50-56-6
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
2 mg/vial
peptides
.,证书
LL37 high purity and High Quality Factory Direct Sales Peptide 99% Purity CAS154947-66-7
-
Price:
$20-25/G FOB
-
CAS No.:
154947-66-7
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
5 mg/vial
peptides
.,证书
- Buying Semaglutide on www.echemi.com where you will find large variety of good choices. ECHEMI emphasizes on verifying suppliers of Semaglutide who have registered on the platform to ensure the accuracy and reliability of suppliers. Safe transaction of chemical will be made based on true information. Buy Semaglutide with 70000+ customers on ECHEMI and make orders now.
- We guarantee the quality of Semaglutide 2924330-56-1 on ECHEMI. Partners on ECHEMI are all selected in certification, qualification or scale. We help buyers to get Semaglutide with various requirement and regulations in global countries and regions. Further services on the whole supply chain can be provided with ECHEMI.
- We are providing better products and services of Semaglutide with fair price and reasonable deal. Member registered on ECHEMI will enjoy services of Semaglutide for example market price and insights and trade data. Efficient order options is the key for supply chain services we offer for you. Buyers are getting help to grow their business internationally on buying Semaglutide.
- •After Semaglutide Patent Expiry in India, the Price System Has Been Restructured as More Than 40 Drugmakers Enter the Competition
- •The $6 Billion Gold Rush: Generic Semaglutide Set to Reshape Global Pharma After Patent Cliff
- •Canada Issues Non-Compliance Notice to Dr. Reddy’s on Semaglutide Generic
- •Torrent Pharma Targets First Wave Semaglutide Launch Revenue Up 11 Percent as Patent Ends
- •New Trial Shows 62 Percent MASH Reversal with Semaglutide as $32 Billion Market Heats Up